Skip to Content

Ionsys Approval History

FDA Approved: Yes (Discontinued) (First approved May 22, 2006)
Brand name: Ionsys
Generic name: fentanyl
Dosage form: Iontophoretic Transdermal System
Company: The Medicines Company
Treatment for: Pain

Marketing Status: Discontinued

Ionsys is a needle-free, patient-activated iontophoretic transdermal analgesic system which uses a weak electric current to rapidly deliver fentanyl across the skin and into the bloodstream. Ionsys is indicated for the short-term management of acute post-operative pain in adult patients requiring opioid analgesia during hospitalization.

Development History and FDA Approval Process for Ionsys

DateArticle
Nov 28, 2005ALZA Corporation Resubmits U.S. New Drug Application for IONSYS (Fentanyl HCl Patient-Activated Transdermal System)
Jul 27, 2004ALZA Corporation Receives Approvable Letter Regarding IONSYS, an Iontophoretic, Fentanyl-containing, Transdermal Analgesic

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide